Literature DB >> 14575437

Isolation and structure determination of lyngbyastatin 3, a lyngbyastatin 1 homologue from the marine cyanobacterium Lyngbya majuscula. Determination of the configuration of the 4-amino-2,2-dimethyl-3-oxopentanoic acid unit in majusculamide C, dolastatin 12, lyngbyastatin 1, and lyngbyastatin 3 from cyanobacteria.

Philip G Williams1, Richard E Moore, Valerie J Paul.   

Abstract

The structure of lyngbyastatin 3 (1), including the configurations of the two unusual amino acid residues, viz., the 3-amino-2-methylhexanoic acid (Amha) and 4-amino-2,2-dimethyl-3-oxopentanoic acid units (Ibu), has been established by chemical degradation. Analysis of the cyanobacterial samples of lyngbyastatin 3 (1), lyngbyastatin 1 (2), and dolastatin 12 (3) demonstrated that they are mixtures of Ibu epimers [R (major) and S (minor)], whereas the structurally related majusculamide C (4) is a single diastereomer having an S-Ibu unit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575437     DOI: 10.1021/np0302145

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  13 in total

1.  Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum.

Authors:  Benjamin R Clark; Niclas Engene; Margaret E Teasdale; David C Rowley; Teatulohi Matainaho; Frederick A Valeriote; William H Gerwick
Journal:  J Nat Prod       Date:  2008-08-13       Impact factor: 4.050

2.  Inhibition of marine biofouling by bacterial quorum sensing inhibitors.

Authors:  Sergey Dobretsov; Max Teplitski; Mirko Bayer; Sarath Gunasekera; Peter Proksch; Valerie J Paul
Journal:  Biofouling       Date:  2011-09       Impact factor: 3.209

Review 3.  Biological targets and mechanisms of action of natural products from marine cyanobacteria.

Authors:  Lilibeth A Salvador-Reyes; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2015-03       Impact factor: 13.423

4.  Veraguamides A-G, cyclic hexadepsipeptides from a dolastatin 16-producing cyanobacterium Symploca cf. hydnoides from Guam.

Authors:  Lilibeth A Salvador; Jason S Biggs; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2011-03-29       Impact factor: 4.050

Review 5.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

6.  Cyclic depsipeptides, grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya cyanobacterium.

Authors:  Christopher C Thornburg; Muralidhara Thimmaiah; Lamiaa A Shaala; Andrew M Hau; Jay M Malmo; Jane E Ishmael; Diaa T A Youssef; Kerry L McPhail
Journal:  J Nat Prod       Date:  2011-08-01       Impact factor: 4.050

7.  Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.

Authors:  Brent K Rubio; Stephen M Parrish; Wesley Yoshida; Peter J Schupp; Tom Schils; Philip G Williams
Journal:  Tetrahedron Lett       Date:  2010-12-22       Impact factor: 2.415

8.  Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.

Authors:  Christopher K Arnatt; Bethany A Falls; Yunyun Yuan; Thomas J Raborg; Ruturaj R Masvekar; Nazira El-Hage; Dana E Selley; Anthony V Nicola; Pamela E Knapp; Kurt F Hauser; Yan Zhang
Journal:  Bioorg Med Chem       Date:  2016-09-26       Impact factor: 3.641

9.  Halogenated fatty acid amides and cyclic depsipeptides from an eastern Caribbean collection of the cyanobacterium Lyngbya majuscula.

Authors:  Jorge I Jiménez; Tifanie Vansach; Wesley Y Yoshida; Bryan Sakamoto; Peter Pörzgen; F David Horgen
Journal:  J Nat Prod       Date:  2009-09       Impact factor: 4.050

10.  Morphological, chemical, and genetic diversity of tropical marine cyanobacteria Lyngbya spp. and Symploca spp. (Oscillatoriales).

Authors:  Robert W Thacker; Valerie J Paul
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.